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Abstract
The transcription factors of the Sox family play important roles in diverse developmental processes. A number of genetic studies have
established that Sox10 is a major regulator of neural crest formation. Here, we report the cloning and functional analysis of the Xenopus
Sox10 gene. Sox10 mRNA accumulates during gastrulation at the lateral edges of the neural plate, in the neural crest-forming region. In
this tissue, Sox10 expression is regulated by Wnt signaling and colocalizes with two major regulators of neural crest formation, Slug and
Sox9. While initially expressed in neural crest cells from all axial levels, at the tailbud stage, Sox10 is downregulated in the cranial neural
crest and persists mostly in neural crest cells from the trunk region. Overexpression of Sox10 causes a dramatic expansion of the Slug
expression domain. We show that the C-terminal portion of Sox10 is sufficient to mediate this activity. Later during embryogenesis,
Sox10-injected embryos show a massive increase in pigment cells (Trp-2-expressing cells). The responsiveness of the embryo to Sox10
overexpression by expansion of the Slug expression domain and ectopic production of Trp-2-positive cells and differentiated melanocytes
is lost during gastrulation, as revealed by a hormone-inducible Sox10 construct. These results suggest that Sox10 is involved in the
specification of neural crest progenitors fated to form the pigment cell lineage.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The neural crest is a multipotent population of migratory
cells that develops at the lateral edges of the neural plate.
During neurulation, neural crest becomes progressively po-
sitioned at the dorsal-most aspect of the neural tube. In most
vertebrates, neural crest arises from the entire length of the
neuraxis starting at a level caudal to the prospective dien-
cephalon. Upon neural tube closure, neural crest cells de-
laminate in a rostrocaudal wave and migrate to diverse
locations throughout the embryo. As they reach their final
locations, neural crest cells have the ability to differentiate
into a large variety of cell types, including peripheral and
enteric neurons and glia, smooth muscle cells, craniofacial
cartilage and bone and endocrine and pigment cells. These
cell types exhibit diversity along the rostrocaudal aspect of
the neuraxis, such that craniofacial cartilage and bone arise
from the cranial region, while sensory neurons/glia and
pigment cells derive from the vagal/trunk region (reviewed
in LeDouarin and Kalcheim, 1999).
Abnormal development of the neural crest and its deriv-
atives has been associated with a large number of diseases
designated under the generic term of neurocristopathies
(Bolande, 1974, 1997). Defining the mechanism of the neu-
ral crest formation represents an important challenge to
further our understanding of the molecular basis underlying
these pathologies. While several models have been pro-
posed to explain induction of neural crest at the neural plate
border (reviewed in Knecht and Bronner-Fraser, 2002; Ay-
* Corresponding author. Fax: 1-215-573-5186.
E-mail address: saintj@vet.upenn.edu (J-P. Saint-Jeannet).
1 Present address: National Institutes of Infectious Diseases, 4-7-1
Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan.
R
Available online at www.sciencedirect.com
Developmental Biology 259 (2003) 19–33 www.elsevier.com/locate/ydbio
0012-1606/03/$ – see front matter © 2003 Elsevier Science (USA). All rights reserved.
doi:10.1016/S0012-1606(03)00161-1
bar and Mayor, 2002), the molecular regulators involved in
neural crest induction and diversification remain largely
unknown.
Sox proteins form a large class of transcriptional regu-
lators characterized by the presence of an HMG-box, a
sequence specific DNA binding domain (Pevney and
Lovell-Badge, 1997; Wegner, 1999). Expression of these
proteins in defined cell types has been implicated in the
control of a variety of developmental processes, including
cell fate decisions (Kamachi et al., 2000). We have recently
shown that one member of this family, Sox9, is expressed in
early neural crest progenitors and is required for develop-
ment of skeletogenic derivatives of the cranial neural crest
during Xenopus embryogenesis (Spokony et al., 2002).
Consistent with this result, mutations in one Sox9 allele
result in Campomelic Dysplasia (CD), a lethal human dis-
order characterized by sex reversal and severe skeletal mal-
formations, including defects in craniofacial skeletal ele-
ments of neural crest origin (Houston et al., 1983; Wagner
et al., 1994). Similarly, Sox9 heterozygous mutant mice
present major skeletal defects, including a shortened jaw
and cleft palate (Bi et al., 2001).
Another Sox family member, Sox10, has also been im-
plicated in neural crest formation. During mouse embryo-
genesis, Sox10 is expressed in the cells of the neural crest at
the time of their emergence and is detected transiently in
enteric neurons and melanoblasts. Sox10 persists in the
peripheral nervous system into adulthood, where it is con-
fined to the peripheral glia (Kuhlbrodt et al., 1998; Pusch et
al., 1998; Britsch et al., 2001). Mutations in one Sox10
allele have been found in patients that suffer from congen-
ital aganglionic megacolon (Hirschsprung disease), some-
times associated with a combination of pigmentation defects
and deafness (Waardenburg–Shah syndrome; Pingault et al.,
1998). In the spontaneous mouse mutant Dom, Sox10 car-
ries a frameshift mutation. As a result, Dom mice suffer
from a loss of neurons and glial cells in the peripheral
nervous system and melanocytes (Southard Smith et al.,
1998; Herbarth et al., 1998; Kapur, 1999). In the zebrafish,
the colourless gene encodes a Sox10 homologue and has
been shown to be required for the specification of a number
of nonectomesenchymal neural crest derivatives (Kelsh and
Eisen, 2000; Dutton et al., 2001).
Here, we report the cloning and functional analysis of the
Xenopus Sox10 gene during development of neural crest-
derived melanocytes. Sox10 mRNA accumulates shortly
after gastrulation in the neural crest-forming region. Ini-
tially, Sox10 is detected in neural crest progenitors from all
axial levels. As development proceeds, Sox10 expression is
downregulated in the cranial region but persists strongly in
the trunk neural crest. Overexpression of Sox10 at the gas-
trula stage, by means of a hormone inducible construct,
causes a dramatic expansion of the Slug expression domain
and leads to a massive increase in differentiated melano-
cytes at a later stage. These results suggest that Sox10 is
involved in the induction of the neural crest-derived pig-
ment cell lineage.
Materials and methods
Isolation of Sox10 and Trp-2
Xenopus Sox10 was amplified by PCR from stage 20
cDNA using degenerate primers (forward: AA[G/A][A/
C]GNCCNATGAA[T/C]GCNTT[T/C]ATG and reverse:
[C/T]TT[A/G]TA[A/G]TGNGC[C/T]TGNAT) based on
the published sequences of chicken (Cheng et al., 2000) and
human (Pusch et al., 1998) Sox10. A 306-bp PCR product
was isolated, ligated into pGEMTeasy (Promega), and se-
quenced by using an automated ABIPrism 373 sequencer.
This PCR product was subsequently used to screen a stage
17 cDNA library (a gift of Dr. Michael King). A 3.3-kb
cDNA was isolated, cloned into pBSK, and sequenced on
both strands (pBSK-Sox10). This clone contains the entire
ORF of Sox10 (1341 bp), 104 bp of 5UTR, and 1881 bp of
3UTR. The complete sequence of Xenopus Sox10 has been
deposited into GenBank (Accession No. AY149116). The
Sox10 ORF was subcloned into the ClaI and XhoI sites of
pCS2 (Turner and Weintraub, 1994). This construct is
referred as pCS2  Sox10. This expression plasmid was
sequenced and the corresponding protein monitored by us-
ing an in vitro transcription/translation coupled rabbit re-
ticulocyte lysate system (TNT, Promega).
Xenopus Trp-2 was amplified by PCR from stage 46
cDNA using degenerate primers (forward: TA[C/T]AA[C/
T]TA[C/T]TT[C/T]GTNTGG and reverse: AANGGNAC-
CAT[A/G]TT[A/G]TA) based on the published sequences
of mouse (Tsukamoto et al., 1992) and chicken (April et al.,
1998) Trp-2. A 760-bp product was recovered, cloned into
pGEMT, sequenced, and subsequently used to generate
Northern and in situ hybridization probes and to design
specific primers for RT-PCR analysis.
Sox10 deletion mutant and hormone-inducible constructs
The Sox10 deletion constructs NSox10 (amino acids
1–95), Sox10C (amino acids 1–200), and Sox10 (amino
acids 176–446) were generated by PCR using pCS2 
Sox10 as template and were cloned into the ClaI and XhoI
sites of pCS2. A Sox10-GR construct was generated by
fusing the coding region of Sox10 to the human glucocor-
ticoid receptor ligand-binding domain (GR) as described
(Gammill and Sive, 1997; Tada et al., 1997). This fusion
construct was subcloned into pCS2 vector. Each expres-
sion plasmid was sequenced and the corresponding protein
monitored by using an in vitro transcription/translation cou-
pled rabbit reticulocyte lysate system in the presence of
[35S]methionine (SP6-TNT; Promega) and resolved on a
NuPAGE BIS–Tris gel (Invitrogen).
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Embryo injections and dexamethasone treatment
Xwnt-1 plasmid DNA (100 pg), GSK3 mRNA (1 ng),
and Sox9 morpholino antisense (Sox9-AS, 10 ng) injections
were performed as described (Saint-Jeannet et al., 1997;
Spokony et al., 2002). A dominant-negative Slug construct
(-Slug) lacking the amino-terminal domain was generated
by PCR as described (LaBonne and Bronner-Fraser, 2000)
and cloned into pCS2 vector. Capped mRNA were syn-
thesized by using an Ambion transcription kit. Injections
were performed in one blastomere at the two-cell stage. For
animal explants experiments, both blastomeres of two-cell-
stage embryos were injected in the animal pole region, and
explants were dissected at the blastula stage and cultured in
vitro. Embryos or animal explants injected with 1 ng of
Sox10-GR or GR mRNA were treated at different time
points with 10 M of dexamethasone (Sigma) in NAM
0.1 (whole embryos) or NAM 0.5 (animal explants) as
described (Gammill and Sive, 1997; Tada et al., 1997).
Western blot analysis
Sox10-GR-injected embryos were collected at different
stages, homogenized, resolved on a NuPAGE BIS–Tris gel,
and blotted onto nitrocellulose. Blots were subsequently
incubated in the presence of a Sox10 polyclonal antibody
(N-20; Santa Cruz Biotechnology) at a 1:100 dilution,
washed, and incubated with anti-goat Ig coupled to horse-
radish peroxidase (Santa Cruz Biotechnology; 1:60,000 di-
lution). The product of the reaction was revealed by using
the SuperSignal West Femto Maximum Sensitivity Sub-
strate from Pierce and detected by exposure onto a BioMax
film (Kodak). This Sox10 antibody does not cross-react
with Sox9 or Sox2 proteins (not shown). Blots were stripped
according to the manufacturer recommendations (Pierce)
and probed with anti--tubulin antibody (Sigma; 1:500 di-
lution).
Northern hybridization and RT-PCR analysis
RNA extraction, electrophoresis, and blotting were per-
formed as described (Taira et al., 1992). For hybridization,
Trp-2 probe was synthesized by using a DNA labeling kit
(-dCTP) from Pharmacia (Ready-To-Go). Filters were an-
alyzed by autoradiography. The RT-PCR primers used in
this study were as follow: EF-1 (forward primer: CAGAT-
TGGTGCTGGATATGC; reverse primer: ACTGCCTT-
GATGACTCCTAG; 268 nt, 22 cycles) and Trp-2 (forward
primer: TGTTACTTGGCATCGTTACC; reverse primer:
GCACTTATCAGATTCGGGTC; 180 nt, 28 cycles).
Lineage tracing and whole-mount in situ hybridization
Embryos were coinjected with -galactosidase mRNA
(-gal, 1 ng). At stage 17 or 32, embryos were fixed in
MEMFA (Harland, 1991) and successively processed for
Red-Gal (Research Organics) staining and in situ hybrid-
ization. Antisense DIG-labeled probes (Genius kit, Roche)
were synthesized by using template cDNA encoding Slug
(Mayor et al., 1995) and Sox9 (Spokony et al., 2002). Sox10
and Trp-2 in situ hybridization was performed by using
pBSK-Sox10 and pGEMT-Trp-2 constructs as templates.
Whole-mount in situ hybridization was performed as pre-
viously described (Harland, 1991). For histology, stained
embryos were embedded into Paraplast, 12 m sections
cut on a rotary microtome and counterstained with eosin.
Results
Cloning of Xenopus Sox10
A PCR product corresponding to a partial sequence of
Xenopus Sox10 was amplified from stage 20 cDNA by
using degenerate primers (Fig. 1). This product was subse-
quently used to screen a stage 17 cDNA library (a gift of
Michael King). A 3.3-kb cDNA was isolated and se-
quenced. The predicted sequence of Xenopus Sox10 en-
codes a 446-amino-acid protein (Fig. 1) that shares 73%
identity with mouse Sox10 (Wagner et al., 1994) and 64%
identity with zebrafish Sox10 (Dutton et al., 2001). When
compared with Xenopus Sox9 (Spokony et al., 2002), the
overall amino acid identity drops to 56%. Based on the
similarity of their HMG domains, Sox genes have been
categorized into several subgroups (Wegner, 1999). Mem-
bers of a subgroup share more than 80% amino acid identity
within the HMG domain, in addition to regions of homol-
ogy outside the HMG box. Sox10 proteins fall into sub-
group E that also includes Sox8 (Bell et al., 2000) and Sox9
(Wagner et al., 1994; Spokony et al., 2002).
Sox10 is expressed in the developing neural crest
To determine the spatial expression pattern of Sox10, we
performed whole-mount in situ hybridization on a variety of
embryonic stages. Sox10 expression is first detected at the
open neural plate stage (stage 13/14; Nieuwkoop and Far-
ber, 1952) in the neural crest-forming regions (Fig. 2A).
This expression pattern at the neural plate border is identical
to that described for Snail (Essex et al., 1993), Slug (Mayor
et al., 1995), Foxd3 (Sasai et al., 2001), and Sox9 (Spokony
et al., 2002). Slug and Sox9 expression at stage 13/14 is
shown for comparison (Fig. 2B and C). Tissue sections of
stage 14 embryos illustrate the neural crest expression of
Sox10 at the neural plate border (Fig. 2D). In Xenopus, the
prospective neural crest is derived from the deep (lateral
neural crest) and the superficial (medial neural crest) layers
of the ectoderm. The cranial neural crest consists of a larger
number of cells than the trunk crest, which remains, at all
times, lateral to the neuraxis (Sadaghiani and Thiebaud,
1987). As the neural tube closes, Sox10 is detected in the
lateral neural crest (Fig. 2E and F). At a similar stage, Sox9
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is expressed in both the lateral and medial neural crest in
addition to the presumptive otic placode (Fig. 2G and H).
By stage 22, neural crest cells migrate in the cranial region
and strong expression of Sox10 is detected in the individual
streams of crest cells that populate the branchial arches as
well as neural crest cells migrating in the frontonasal region
(Fig. 2I). Sox10 is also strongly expressed at the dorsal
midline, in the trunk neural crest (Fig. 2I). Around stage 25,
Sox10 is detected in the otic vesicle (Fig. 2J and K) and will
persist in this tissue at least until stage 40 (Fig. 2Q and R).
Tissue sections of stage 25 embryos illustrate the massive
expression of Sox10 in the premigratory trunk neural crest
cells on top of the neural tube (Fig. 2L). Around stage 30,
Sox10 expression is downregulated in the cranial neural
crest of the pharyngeal arches but persists in the trunk
neural crest, in the otic vesicle, and in discrete domains
adjacent to the hindbrain (Fig. 2M N and P). Sox10 expres-
sion in the epithelium of the developing inner ear is con-
sistent with its expression in other species (Bondurand et al.,
1998; Southard-Smith et al., 1998; Watanabe et al., 2000;
Fig. 1. Sequence and structure of Xenopus Sox10. Deduced amino acid sequences from Xenopus, mouse, zebrafish Sox10, and Xenopus Sox9 were aligned
by using Mac Vector CustalW Alignment. Identical and similar amino acids are in black and gray boxes, respectively. The HMG box is underlined in black.
The position of the degenerate primers used to isolate Xenopus Sox10 is indicated by red arrows.
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Cheng et al., 2000; Dutton et al., 2001). For comparison, at
a similar stage, Sox9 is still strongly expressed in the pha-
ryngeal arches, the otic vesicle, and the eye (Fig. 2O), but is
totally absent from the trunk neural crest (Spokony et al.,
2002). At the latest stage analyzed in this study (stage 40),
Sox10 expression is restricted to the otic vesicle, differen-
Fig. 2. Developmental expression of Sox10 by whole-mount in situ hybridization. (A) Sox10 expression at the neurula stage (stage 14) is detected at the lateral
edges of the neural plate. Slug (B) and Sox9 (C) expression at a similar stage are shown for comparison. (A–C) Dorsal views, anterior to top. (D) Transverse
section of a stage 14 embryo. Sox10 expression is restricted to the neural crest-forming region. (E–H) Stage 16 embryo, dorsal (E, G) or lateral (F, H) views,
anterior to top. As the neural tube closes, Sox10 (E, F) remains strongly expressed in the neural crest at all axial levels. Sox9 expression (G, H) is shown
for comparison. (I) At stage 22, Sox10 is detected in migrating cranial neural crest cells (red arrow) as well as in neural crest at the dorsal midline in the
trunk region (green arrow). An additional domain of expression includes the otic placode (yellow arrow). Dorsal view, anterior to top. (J–L) In stage 25
embryos, Sox10 is detected in the streams of cranial neural crest that populate the branchial arches (red arrows), in the dorsal aspect of the neural tube (green
arrow) and in the otic placode (yellow arrow). Lateral (J) and dorsal (K) views, anterior to left. (L) Transverse section of a stage 25 embryo, highlights Sox10
expression in neural crest progenitors at the dorsal midline. (M-P) At stage 32, Sox10 expression is downregulated in the branchial arches but persists in the
otic vesicle (yellow arrow), at the dorsal midline (green arrow), in the forebrain, and in discrete domains adjacent to the hindbrain. Lateral (M) and dorsal
(P) views, anterior to left. Higher magnification view of Sox10 expression in the head (N). Sox9 expression in the head of an embryo at a similar stage is
shown for comparison (O). In a lateral view of an embryo at stage 35 (Q), Sox10 is detected in the forebrain, the otic vesicle (yellow arrow), a number of
cranial ganglia and in differentiating melanoblasts. (R) Transverse section at the level of the hindbrain illustrates Sox10 expression in the otic vesicle (yellow
arrow) and adjacent VII/IX cranial ganglion (purple arrow).
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tiated pigment cells, and in several cranial ganglia (Fig. 2Q
and R).
Regulation of Sox10 expression in the neural crest-
forming region
Studies in the mouse (Ikeya et al., 1997; Dunn et al.,
2000), frog (Saint-Jeannet et al., 1997, Chang and Hem-
mati-Brivanlou, 1998; LaBonne and Bronner-Fraser, 1998;
Bang et al. 1999; Deardorff et al., 2001; Tan et al., 2001),
zebrafish (Dorsky et al., 1998), and chick (Garcia-Castro et
al., 2002) have implicated the Wnt family of growth factors
in neural crest formation (reviewed in Wu et al., 2003).
Ectopic Wnt expression enhances, whereas lack of Wnt
signaling inhibits neural crest formation in vivo (Saint-
Jeannet et al., 1997; Labonne and Bronner-Fraser, 1998;
Deardorff et al., 2001). We analyzed whether Wnt signaling
also regulates Sox10 expression in the neural crest-forming
region. Injection of Xwnt-1 plasmid DNA (100 pg) into one
blastomere at the two-cell stage elicited ectopic expression
of Sox10 at stage 17 (Fig. 3A) in more than 80% of the
embryos (n  50), without affecting axis formation (Saint-
Jeannet et al., 1997). Conversely, injection of 1 ng of gly-
cogen synthase kinase 3 (GSK3) mRNA, a downstream
component of the canonical Wnt pathway known to antag-
onize Wnt signaling (He et al., 1995), blocked Sox10 ex-
pression (Fig. 3A) in 65% of the embryos (n  51). These
results indicate that Wnt signaling regulates Sox10 and Slug
expression in a similar manner, suggesting that both tran-
scription factors may act in the same pathway during neural
crest formation.
Previous work has established that Slug and Sox9 are
essential components of the signaling cascade leading to
neural crest formation, as Slug or Sox9 loss-of-function
leads to a specific loss of neural crest progenitors (LaBonne
and Bronner-Fraser, 2000; Spokony et al., 2002). Therefore,
we tested whether Sox10 expression in the neural crest-
forming region is dependent on these factors. Injection of
either 10 ng of Sox9-AS (Spokony et al., 2002) or 1 ng of
a dominant negative Slug mRNA, Slug (LaBonne and
Bronner-Fraser, 2000), resulted in a severe loss of Sox10
expression on the injected side of stage 17 embryos (Fig.
3B), similar to that observed for Slug (Fig. 3B; LaBonne
and Bronner-Fraser, 2000; Spokony et al., 2002). These
results indicate that Sox9 and Slug, two major regulators of
neural crest formation in Xenopus, are required for Sox10
expression at the neural plate border. Interestingly, Sox9
and Slug overexpression can upregulate Sox10 expression
in the neural crest-forming region (Fig. 3C). The mutual
regulation of Sox9, Slug, and Sox10 indicates that these
factors may be involved in maintaining each other’s expres-
sion. This type of reciprocal activation loops has also been
implicated in the maintenance of Zic-r1, FoxD3, and Slug
expression at the neural plate border (Sasai et al., 2001).
The C-terminal domain of Sox10 is sufficient to mediate
Sox10 function
To evaluate Sox10 function during neural crest forma-
tion, we analyzed the effect of Sox10 overexpression on the
formation of neural crest progenitors, as determined by
expression of the early neural crest marker, Slug. Injection
of 1 ng of Sox10 mRNA in one blastomere at the two-cell
stage resulted in a dramatic lateral expansion of Slug ex-
pression domain (Fig. 4A and B) in approximately 60% of
the injected embryos (n  264). This result suggests that
Fig. 3. Regulation of Sox10 expression in the neural crest-forming region. (A) Regulation of Sox10 and Slug expression by Wnt signaling. Injection of Xwnt-1
plasmid (100 pg) expands Slug (79%, n  53) and Sox10 (82%, n  50) expression domains. Conversely, overexpression of GSK3 (1 ng), known to block
Wnt signaling, prevents Slug (81%, n  42) and Sox10 (65%, n  51) expression on the injected side. (B) Sox9 and Slug are required for Sox10 expression.
Sox9-AS injection (10 ng) blocks Slug (89%, n  35) and Sox10 (96%, n  54) expression. Similarly, a dominant negative Slug (Slug, 1 ng) blocks Slug
(61%, n  51) and Sox10 (56%, n  50) expression. (C) Sox9 and Slug overexpression upregulate Sox10 expression. Sox9 (1 ng) overexpression leads to
a limited expansion of Slug (83%, n  58) and Sox10 (96%, n  79) expression domains. Overexpression of Slug (0.1 ng) results in a robust expansion of
Slug (90%, n  30) and Sox10 (98%, n  44). In all panels, early neurula stage embryos are viewed from the dorsal side, anterior to top. RNA encoding
the lineage tracer -galactosidase was coinjected to identify the injected side (red staining), the right side in all panels.
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Sox10 is sufficient to induce neural crest progenitors and
therefore places Sox10 in the complex regulatory cascade
controlling neural crest formation.
Based on this initial observation, we decided to use
Sox10-mediated Slug expansion as an assay to perform a
structure-function analysis of the Sox10 protein. We gener-
ated three deletion constructs, Sox10, Sox10C, and
NSox10 (Fig. 4B), and tested their ability to expand Slug
expression at stage 17, after unilateral injection of the cor-
responding mRNA at the two-cell stage. While the N-ter-
minal domain alone (Nsox10) had no effect on endogenous
Slug expression (Fig. 4A and B), a construct lacking the
C-terminal putative transcriptional activation domain of
Sox10 (Sox10C) led to a moderate loss of Slug expression
on the injected side in 40% of embryos, possibly by acting
as a dominant-negative (Fig. 4A and B). By contrast, a
construct lacking the N-terminal domain and the HMG-box
(Sox10) generated dramatic expansion of Slug expression
domain, similar to wild type Sox10 overexpression, and at a
similar frequency (Fig. 4A and B). These results indicate
that the N-terminal domain and the HMG-box are dispens-
able for Sox10 activity in the context of this assay and
suggest that the C-terminal domain of Sox10 carries suffi-
cient information to mediate Sox10 function, presumably by
establishing interactions with specific partner molecules
(Kamachi et al., 2000).
Sox10 expression is sufficient to induce pigment cell
lineage
Melanocytes represent one major derivative of the neural
crest, and Sox10 has been implicated in the formation of this
cell type, as mutations in Sox10 result in pigmentation
defects (Pingault et al., 1998; Southard-Smith, 1998; Her-
barth et al., 1998; Dutton et al., 2001). Therefore, we de-
cided to further characterize the neural crest derivatives
generated by Sox10 overexpression, by focusing primarily
on the pigment cell lineage. To this end, we cloned a partial
sequence of Xenopus tyrosinase related protein-2 (Trp-2), a
pigment cell-specific enzyme involved in melanin synthesis
(Tsukamoto et al., 1992). By Northern blot analysis, Trp-2
transcripts are detected around stage 30 (Fig. 5A), while the
Fig. 4. The C-terminal domain of Sox10 is sufficient to induce neural crest progenitors. (A) Embryos were injected in one blastomere at the two-cell stage
with mRNA encoding either wild type Sox10 (Sox10) or various Sox10 deletion constructs (Sox10, Sox10C, or Nsox10) and analyzed for Slug expression
at stage 17. Sox10 injection (1 ng) expands Slug expression domain (white arrow). A transverse section through a Sox10-injected embryo illustrates Slug
expansion on the injected side (black arrow). Sox10-injected embryos (1 ng) display a dramatic expansion of the Slug expression domain. By contrast,
injection of Sox10C (2 ng) resulted in a moderate inhibition of Slug expression, whereas NSox10-injected embryos (1 ng) were unaffected. RNA encoding
the lineage tracer -galactosidase was coinjected to identify the injected side (red staining), the right side in all panels. (B) Schematic representation of wild
type Sox10 and various Sox10 deletion constructs. The HMG box is depicted in blue. Quantification of the in situ hybridization results. (1), expansion of
Slug expression domain; (2), reduction of Slug expression domain; (3), Slug expression domain is unaffected. N, number of cases analyzed.
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first pigmented melanophores appear a few hours later
around stage 33 (Nieuwkoop and Farber, 1950). By whole-
mount in situ hybridization, Trp-2 is first detected in the
developing eye at stage 26, in the dorsal aspect of the retina
(not shown). A few hours later at stage 27/28, Trp-2 is
expressed at the dorsal midline in the trunk and vagal
regions of the embryo (Fig. 5B). Eventually, Trp-2 expres-
sion will persist at all sites of pigment cell differentiation
(not shown).
Upon injection of 1 ng of Sox10 mRNA in one blas-
tomere at the two-cell stage, approximately 20% of injected
embryos (n  51) exhibited a massive overproduction of
pigment cells precursors on the injected side (Fig. 5C), as
assayed by Trp-2 expression at stage 33. This effect is
specific to Sox10 since neither Sox2 (Misuzeki, 1998) nor
Sox9 (Spokony et al., 2002) overexpression was able to
mimic this activity (data not shown). However, the tran-
scription factor Slug has also been shown to induce ectopic
pigment cells upon overexpression in the embryo (LaBonne
and Bronner-Fraser, 1998). Animal explants isolated at the
blastula stage from embryos overexpressing Sox10 showed
strong activation of Trp-2 expression by RT-PCR and by in
situ hybridization at stage 33 (Fig. 5D and E). Interestingly,
animal explants derived from embryos injected with Sox9
or Slug mRNA failed to activate Trp-2 expression (Fig. 5D
and E). This is consistent with previous work showing that
Slug expression in animal explants is not sufficient to in-
duce a neural crest differentiation program (LaBonne and
Bronner-Fraser, 1998). Nevertheless, we cannot exclude the
possibility that the differences in activity between Sox10
and other neural crest effectors (Sox9 and Slug) may be due
to the production of insufficient levels of active protein. The
winged-helix gene Foxd3 has been reported to induce me-
lanocytes when expressed in animal explants (Sasai et al.,
2001), suggesting that Sox10 and FoxD3 may act in the
same pathway during pigment cell formation. Altogether,
Fig. 5. Sox10 is sufficient to induce pigment cell lineage as revealed by Trp-2 expression. (A) Developmental expression of Xenopus Trp-2 by Northern
hybridization. The stages are according to Nieuwkoop and Farber (1967). (B) By whole-mount in situ hybridization at stage 27/28, Trp-2 is detected in the
developing retina and in individual cells scattered at the dorsal midline at a level posterior to the hindbrain. Dorsal view, anterior to the left. (C) An embryo
injected at the two-cell stage with 1 ng of Sox10 mRNA and analyzed at stage 30 displays massive ectopic expression of Trp-2 (left panel), while the
uninjected side is unperturbed (right panel). Lateral view, anterior is to the right. (D) RT-PCR analysis of animal explants derived from embryos injected
at the two-cell stage with 1 ng of Sox9 or Sox10 mRNA. Only Sox10 overexpression induces strong expression of Trp-2 at stage 33. EF1- is used as a
loading control. (E) In situ hybridization of explants overexpressing Sox9, Sox10, or Slug. Induction of Trp-2 is exclusively detected in Sox10-injected animal
explants at equivalent stage 32. Trp2 expression in an uninjected embryo (control) at stage 32 is shown (left panel).
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these results indicate that Sox10 expression is sufficient to
activate a melanocyte differentiation program in the whole
embryo, as well as in animal explants.
Sox10 function at the gastrula stage regulates the
generation of neural crest-derived pigment cells
The results presented here indicate that Sox10 is impli-
cated in the formation of neural crest progenitors fated to
form the pigment cell lineage. We next decided to determine
the window of time during which Sox10 is functioning to
generate melanocytes. To this end, we generated an induc-
ible Sox10 construct (Sox10-GR) in which the hormone-
binding domain of the human glucocorticoid receptor is
fused in frame with Sox10 protein. This construct allows
temporal activation of Sox10 protein by addition of dexa-
methasone at specific times during embryogenesis (Gam-
mill and Sive, 1997; Tada et al., 1997). Embryos were
injected in one blastomere at the two-cell stage with 1 ng of
Sox10-GR mRNA and treated with dexamethasone at var-
ious stages. Addition of dexamethasone at the blastula (st.
6) and gastrula (st. 10–12) stages caused expansion of Slug
expression at stage 17 (Fig. 6A and C). This result is
consistent with the phenotype generated by Sox10 overex-
pression described earlier (Fig. 4) and suggests that this
fusion construct is fully active. However, addition of dexa-
methasone at the end of gastrulation (st. 13) failed to expand
Slug expression. In a similar manner, ectopic expression of
Trp-2 at stage 32 (Fig. 6B and C) was only observed when
dexamethasone was added at the blastula and gastrula stages
(st. 6–12). At the neurula stage (st. 13–16) and during the
phase of neural crest cell migration (st. 22–25), addition of
Fig. 6. Sox10 expands Slug and induces ectopic Trp2-expressing cells and melanocytes at the gastrula stage. (A) Ectopic Slug expression in embryos injected
with Sox10-GR at the two-cell stage and treated with dexamethasone at stage 6 or stage 10 (left panels). Slug expression on the uninjected side is shown
for comparison (right panels). (B) Ectopic Trp-2 expression in embryos injected with Sox10-GR at the two-cell stage and treated with dexamethasone at stage
10 (upper left panel). Trp-2 expression is unaffected in the neural crest lineage of embryos treated with dexamethasone at stage 13 (lower left panel). When
targeted in the head region, Sox10-GR blocks Trp-2 expression in the pigmented epithelium of the retina (arrow, left panel). Trp-2 expression on the
uninjected side is presented for comparison (right panels). Lateral view, anterior is to the left (left panels) or to the right (right panels). RNA encoding the
lineage tracer -galactosidase was coinjected to identify the injected side (red staining). (C) Quantification of the in situ hybridization results. The number
of cases analyzed for each time point (Dex) is indicated in parentheses. (D) Western blot analysis. Detection of Sox10-GR protein in extracts from
Sox10-GR-injected embryos (Sox10-GR) collected at different stages after injection at the two-cell stage. The fusion protein is expressed at similar levels
at all stages (st 10–22). This Sox10 antibody does not allow detection of endogenous Sox10 protein (first lane). Tubulin is presented as a loading control.
(E) Development of ectopic melanocytes in Sox10-GR-injected embryos. Embryos injected with Sox10-GR at the two-cell stage and treated with
dexamathasone at stage 10 (upper panel, Dex st 10) displays ectopic formation of pigment cells in the head (white arrow) and the trunk (black arrows)
regions. The pattern of pigment cells is unaffected in sibling embryos treated with dexamethasone at stage 16 (lower panel, Dex st 16). (F) Induction of
differentiated melanocytes in animal explants at equivalent stage 40. Animal explants isolated at the blastula stage from embryo injected with 2 ng of
Sox10-GR mRNA at the two-cell stage were treated with dexamethasone at stage 9 (Dex st. 9) or at stage 16 (Dex st. 16). Induction of melanocytes is
only observed in animal explants treated by dexamethasone at stage 9.
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dexamethasone failed to generate ectopic Trp-2 cells (Fig.
6B and C). Overall, Sox10-GR is a more potent inducer of
Slug and Trp-2 than wild type Sox10. As a control, injec-
tions of GR mRNA had no effect on endogenous Slug and
Trp-2 expression after addition of dexamethasone (not
shown).
By Western blot analysis, using a Sox10-specific anti-
body, we showed that the levels of Sox10-GR protein re-
mained constant throughout development, from stage 10 to
22 (Fig. 6D). This result indicates that the lack of Slug/Trp-
2-inducing activity of Sox10-GR at stage 13 and beyond is
not due to a reduced accumulation of Sox10-GR protein at
these later stages, further validating the temporal require-
ment for Sox10 function during gastrulation.
In Sox10-GR-injected embryos, the development of dif-
ferentiated melanocytes, at stage 40, was also dependent on
the addition of dexamethasone prior to stage 13 (Fig. 6E). In
these embryos, supernumerary pigment cells were found in
the head region and at the dorsal midline in the trunk (Fig.
6E), though at a lower frequency than ectopic Trp-2-ex-
pressing cells. Sox10-GR-injected embryos treated with
dexamethasone at stage 16 had a normal pattern of differ-
entiated pigment cells (Fig. 6E). Similarly, animal explants
derived from Sox10-GR-injected embryos formed differen-
tiated melanocytes only when exposed to dexamethasone
before stage 13 (Fig. 6F). These results indicate that, in
whole embryos and in animal explants, Sox10 has the same
temporal requirement to generate differentiated melano-
cytes.
In contrast to these results, a reduction or a loss of
pigment cells of nonneural crest origin (retinal pigmented
epithelium) was observed when Sox10-GR expression was
targeted in the head region (Fig. 6B, left middle panel). This
result indicates that these two populations of melanoblasts
behave differently in response to Sox10 overexpression. A
similar difference in the way these two types of melanocytes
are affected was also reported in mice embryos carrying
mutation in Mitf, a downstream target of Sox10 (Nakayama
et al., 1998). Alternatively, by expanding the neural crest
domain, Sox10 overexpression may perturb anterior neural
plate patterning, leading to an indirect effect on the pig-
mented epithelium of the retina.
Altogether, these results indicate that the ability of the
embryo to respond to Sox10 overexpression by expansion
of Slug expression domain and ectopic production of Trp-
2-expressing cells and differentiated melanocytes are lost
during gastrulation in whole embryo and animal explants,
suggesting that Sox10 functions in the early phases of neu-
ral crest specification to generate the pigment cell lineage.
Increased pigment cells in response to Sox10
overexpression do not result from a conversion of cranial
neural crest into trunk crest
The formation of supernumerary melanocytes in em-
bryos overexpressing Sox10 could be explain by a conver-
sion of cranial crest into trunk neural crest rather than by a
de novo induction of neural crest progenitors. Previous
studies have shown that Sox9 depletion in Xenopus, by
means of a morpholino antisense oligonucleotide (Sox9-
AS), results in a loss cranial neural crest (Spokony et al.,
2002). Therefore, we analyzed the pattern of pigment cells
in embryos overexpressing Sox10 and in which the devel-
opment of cranial neural crest cells has been compromised
by injection of Sox9-AS. The prediction is that, if conver-
sion from cranial to trunk crest occurs, formation of ectopic
pigment cells observed in Sox10-injected embryos, at stage
40, should be dramatically impaired in the context of Sox9-
depleted embryos. Our results indicate that ectopic forma-
tion of pigment cells in Sox10-GR-injected embryos,
treated with dexamethasone at stage 10, is not significantly
different in the context of Sox9-depleted embryos as com-
pared with embryos expressing normal levels of Sox9 (Ta-
ble 1), suggesting that supernumerary pigment cells induced
by Sox10 overexpression do not result from a conversion of
cranial into trunk neural crest. This conclusion is further
supported by the observation that Sox10 overexpression
does not lead to noticeable craniofacial defects.
Discussion
In this study, we report the cloning of the Xenopus Sox10
gene and describe its expression in the neural crest-forming
region of the embryo. In this tissue, Sox10 expression is
regulated by Wnt signaling and colocalizes with Slug and
Sox9, two major regulators of neural crest formation. Sox10
overexpression at the gastrula stages, using a hormone-
inducible construct, expands neural crest progenitors. Later
in embryogenesis, this expansion of neural crest progenitors
is correlated with a massive overproduction of pigment
cells. These results indicate that Sox10 is an important
component of the regulatory cascade involved in neural
crest formation and support the existence of a Sox10-de-
pendent pathway involved in the induction of neural crest
progenitors fated to form melanocytes.
Table 1
Increased pigment cells induced by Sox10 overexpression do not result
from a conversion of cranial neural crest into trunk/vagal neural crest
Dex st. 10 n Number of pigment cells
Normal Increased Reduced
Sox9-AS  66 82%  18%
Sox10-GR  29 100%  
Sox10-GR  55 35% 65% 
Sox10-GR
 Sox9-AS  36 89%  11%
Sox10-GR
 Sox9-AS  34 32% 56% 12%
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Significance of Sox10 expression pattern for neural crest
formation
Sox10 accumulates shortly after gastrulation at the lat-
eral edges of the neural plate. In this tissue, it colocalizes
with a number of early genes activated in response to neural
crest-inducing signals, including Slug, Snail, Sox9, and
FoxD3. Temporally, these genes precede Sox10 expression
by a few hours (Mayor et al., 1995; Essex et al., 1993;
Linker et al., 2000, Sasai et al., 2002, Spokony et al., 2002).
A similar delay in Sox10 expression as compared with Slug
was also reported in chick neural crest progenitors (Cheng
et al., 2000). Following its initial activation at the neural
plate border, Sox10 is broadly expressed in neural crest
progenitors along the entire anteroposterior axis, similar to
Sox9 (Spokony et al., 2002), with Sox10 being excluded
from the medial neural crest. As neural crest cell migration
is initiated, Sox10 is strongly expressed in cranial neural
crest cells as they migrate into the branchial arches. This is
consistent with Sox10 expression pattern in chick and hu-
man (Cheng et al., 2000; Bondurand et al., 1998) but is in
contrast to mouse and zebrafish, in which Sox10 is not
expressed in migrating cranial neural crest cells (Kuhlbrodt
et al., 1998; Dutton et al., 2002). By the tailbud stage, Sox9
and Sox10 develop complementary and nonoverlapping ex-
pression domains. While Sox9 expression persists primarily
in cranial neural crest cells of the pharyngeal arches, Sox10
expression is downregulated in the cranial region and is
exclusively maintained in trunk neural crest cells at the
dorsal midline of the neural tube.
Humans, mice, and zebrafish carrying mutations in
Sox10 (Pingault et al., 1998; Southard-Smith, 1998; Her-
barth et al., 1998; Dutton et al., 2001) suffer from defects in
vagal/trunk neural crest derivatives (enteric ganglia, pig-
ment cells, and dorsal root ganglia), but not in cranial
(craniofacial cartilages and bones) or cardiac (outflow tract
of the heart) neural crest derivatives (Kapur, 1999), sug-
gesting a strict requirement for Sox10 in vagal and trunk
neural crest derivatives. Consistent with this view, Sox9
depletion in Xenopus embryos, using morpholino antisense
oligonucleotides, resulted in defects in craniofacial skeletal
elements, while pigment cell lineage appeared to be largely
unperturbed (Spokony et al., 2002). This interesting parallel
between Sox9 and Sox10 function in the cranial and trunk/
vagal neural crest, respectively, suggests that differentially
expressed Sox proteins are required for the development of
distinct neural crest derivatives as they emerge from differ-
ent axial levels (Fig. 7). However, it is not clear whether
Sox9 is also required for the development of cardiac neural
Fig. 7. Sox proteins regulate the development of neural crest derivatives from different axial levels. Sox proteins differentially expressed in neural crest
progenitors are involved in the development of neural crest derivatives from different axial levels. Sox9 and Sox10, respectively, function in the formation
of cranial (cartilage and bone) and trunk/vagal (pigment cells, enteric and sensory ganglia) neural crest derivatives. Whether Sox9 or another Sox family
member is involved in the development of cardiac neural crest lineage remains to be determined. F, forebrain; H, hindbrain; M, midbrain; S, spinal cord.
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crest derivatives or whether a distinct family member is
required for this lineage (Fig. 7).
Position of Sox10 in the regulatory cascade leading to
neural crest formation
The Wnt signaling pathway has been implicated in neu-
ral crest formation in a number of species (reviewed in Wu
et al., 2003). Sox10 is regulated by Wnts as activation of
Wnt signaling expands, whereas blockage of Wnt signaling
inhibits Sox10 expression in the neural crest-forming re-
gion. This result indicates that Sox10 expression is regu-
lated by Wnt signaling and also suggests the existence of a
pathway required for Sox10 activation at the neural plate
border. A number of genes involved in the control of neural
crest formation, including Slug, Sox9, and AP2, have also
been shown to be regulated by Wnt signaling in vivo (Saint-
Jeannet et al., 1997; LaBonne and Bronner-Fraser, 1998;
Deradorff et al., 2001; Luo et al., 2003), suggesting that
these factors may act in the same regulatory pathway, or that
they may act in parallel pathways sharing a common up-
stream Wnt regulator.
In Xenopus, a number of transcription factors have been
found to be expressed in the developing neural crest, in-
cluding Slug, (Mayor et al., 1995), Snail (Essex et al.,
1993), Twist (Hopwood et al., 1985), Pax3 (Bang et al.,
1997), Zic3 (Nakata et al., 1997), Zic5 (Nakata et al., 2000),
Foxd3 (Dirksen and Jamrich, 1995; Sasai et al., 2001), Sox9
(Spokony et al., 2002), and AP2 (Luo et al., 2003). Some of
these factors have also been implicated at different levels in
the regulation of neural crest formation, migration, or both
(Nakata et al., 1997; Nakata et al., 2000; LaBonne and
Bronner-Fraser, 2000; Pohl and Knochel, 2001; Sasai et al.,
2001; Spokony et al., 2002; Luo et al., 2003).
We found that loss of Slug or Sox9 function in the
developing embryo prevented Sox10 expression, indicating
that Slug and Sox9 are both required for Sox10 expression.
This also suggests that Slug and Sox9 may act upstream of
Sox10 during neural crest formation, consistent with the
timing of Sox10 versus Slug/Sox9 expression at the neural
plate border. However, Slug, Sox9, and Sox10 appear to be
regulating each other’s expression in a manner suggesting
that they may be reciprocally involved in maintaining their
expression, as previously described for other genes ex-
pressed at the neural plate border (Sasai et al., 2001). While
it is somewhat difficult to understand the early regulation of
Sox9 by Sox10, it may indicate that Sox genes may have
multiple essential roles during the steps leading to develop-
ment of the neural crest, initially in the specification of
progenitors from different axial levels and later in the dif-
ferentiation of these precursors into specific lineages. Re-
cent studies on zebrafish Sox9 suggest that this might be the
case (Yan et al., 2002; Li et al., 2002).
In all, these results indicate that Sox10 is a component of
the regulatory cascade leading to neural crest formation.
However, further studies will be needed to fully characterize
and understand the hierarchy of the molecular regulators
involved in the multiple steps leading to the generation of
neural crest progenitors.
Functional domains of Sox10 protein
Sox proteins are characterized by the presence of a HMG
box (DNA binding domain) encoded by a domain of about
80 amino acids and a transactivation domain at the C-
terminal portion of the molecule. Sox proteins are believed
to regulate their target genes through interaction with spe-
cific partner factors allowing Sox proteins to act in a cell-
specific manner (Kamachi et al., 2000).
Our structure-function analysis revealed that the C-ter-
minal domain of Sox10, in the absence of the DNA binding
domain (Sox10 construct), is sufficient for Sox10-medi-
ated activation of Slug. This result predicts that at least one
Sox10-interacting molecule is capable of mediating Sox10
function in the absence of the HMG box. Therefore, it can
be argued that the Sox10-interacting partner is sufficient to
recruit Sox10 to the DNA, in the vicinity of Sox10-target
gene, thereby allowing transcription through the unaltered
Sox10 transactivation domain. By extension, we can predict
that in the developing embryo Sox10 activity will be largely
dependent on the availability of this putative partner mole-
cule. Candidate partner molecules that interact with Sox10
to regulate expression of target genes include Pax3 (Bon-
durand et al., 2000; Potterf et al., 2000; Lang et al., 2000)
and the POU-domain protein Tst-1/Oct6/SCIP (Kuhlbrodt
et al., 1998). In Xenopus, Pax3 is expressed in the neural
crest-forming region (Bang et al., 1997; 1999) and is there-
fore a viable candidate to play this role. Whether Pax3 or
any other factors directly interact with Sox10 at the neural
plate border remains to be determined. Moreover, the char-
acterization of downstream target genes for Sox10 is critical
to further our understanding of Sox10 function in the con-
text of the developing neural crest.
Role of Sox10 in neural crest-derived melanocytes
formation
Melanocytes represent one major derivative of the neural
crest. These cells start as nonpigmented precursors, or mela-
noblasts, migrating along specific dorsolateral pathways
into the epidermis. Initially, there is a difference in the
production of melanoblasts between the cephalic and the
trunk neural crest. In amphibian embryos, it is believed that
a majority of melanoblasts are derived from the trunk and
that approximately one-third of melanoblasts are contrib-
uted by the cephalic region (Model and Dalton, 1968). All
the pigment cells of the body originate from the neural crest
except the pigment cells of the retina, which derive from the
neural epithelium of the optic vesicle.
A number of genes, including Mitf, c-kit, Pax3, Ednrb,
and End3, have been implicated in the development of the
melanocyte lineage (reviewed in Goding, 2000). A current
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model of the transcriptional hierarchy involved in melano-
cyte formation placed Sox10 upstream of Mitf and c-Kit.
Consistent with this model, homozygous Sox10 mutant
mice are severely deficient in melanoblasts (Pingault et al.,
1998; Southard-Smith, 1998; Potterf et al., 2001), and these
cells failed to express markers such as Mitf, Trp-2, and c-kit
(Brisch et al., 2001; Potterf et al., 2001).
Because Sox10 overexpression expands both the pan-
neural crest (Slug) and a melanocyte-specific marker (Trp2),
it was critical to define more precisely the window of time
during which Sox10 is functioning. When Sox10-GR-in-
jected embryos were treated with dexamethasone prior to or
during gastrulation, expression of Slug and Trp-2 were
greatly increased. Expansion of Slug and Trp-2 at stage 17
and stage 32, respectively, suggests that the expression of
both genes have a similar requirement with regard to Sox10.
Addition of dexamethasone during the phases of neural
crest migration (stage 22 and beyond) was not able to
induce ectopic production of Trp-2-positive cells and, there-
fore, rules out an involvement of Sox10 in neural crest
migration.
We have shown that supernumerary pigment cells in-
duced by Sox10 overexpression do not result from a con-
version of cranial neural crest into trunk/vagal neural crest.
Two pieces of evidence support this view: (1) Sox10 over-
expression do not lead to craniofacial defects, and (2) in
embryos lacking Sox9 protein, which are believed to be
deficient in cranial neural crest (Spokony et al., 2002),
ectopic formation of pigment cells by Sox10 overexpression
is not significantly lower than in embryos expressing normal
levels of Sox9 (Table 1). This suggests that increased pig-
ment cells observed upon Sox10 overexpression result from
the induction of ectopic trunk neural crest progenitors. Al-
ternatively, one cannot exclude the possibility that these
cells may arise from the direct conversion of epidermal
ectoderm into melanocytes. However, the parallel between
Slug expansion (at early stage) and ectopic production of
Trp-2-positive cells/melanocytes (at later stage) favors the
interpretation of a Sox10-mediated induction of crest pro-
genitors.
Loss of Sox10 function in the mouse and zebrafish
(Southard-Smith et al., 1997; Kapur et al., 1999; Sonnen-
berg-Reithmacher et al., 2001; Dutton et al., 2002) has been
shown to result in increased apoptosis of nonectomesenchy-
mal neural crest progenitors, supporting a role for Sox10 in
neural crest survival. Our results indicate that Sox10 is also
implicated in the specification of neural crest progenitors,
including those fated to form the pigment cell lineage.
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